Elsevier, The Lancet, 9201(355), p. 376-377
DOI: 10.1016/s0140-6736(99)03882-9
Full text: Download
A series of 32 recipients of liver, kidney, or pancreas transplants who were treated with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent graft function without drug-related toxic effects.